Yüklüyor......

Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

The antitumorigenic mechanism of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib is still a matter of debate. Using lung cancer cell lines (A549, H460) and metastatic cells derived from a lung cancer patient, the present study investigates the impact of celecoxib on the expression of inte...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Schellhorn, Melina, Haustein, Maria, Frank, Marcus, Linnebacher, Michael, Hinz, Burkhard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4770776/
https://ncbi.nlm.nih.gov/pubmed/26513172
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!